Evidence-Based Best Practices™

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

Meeting Slides

Clinical Practice Guidelines

ASHP Guidelines on Pharmacist Involvement in HIV Care.

Schafer JJ, et al. Am J Health Syst Pharm.2016;73(7):468-494.

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents.

US Department of Health and Human Services, 2017.

Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living With HIV.

US Department of Health and Human Services, 2018.

Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations.

Centers for Disease Control and Prevention, 2018.

Screening Guidelines for Non–AIDS-defining Cancers in HIV-Infected Individuals.

Mani D, Aboulafia DM. Curr Opin Oncol. 2013;25(5):518-525.

STD and HIV Screening Recommendations.

Centers for Disease Control and Prevention, 2017.

Updated PrEP Clinical Practice Guideline and PrEP Clinical Providers’ Supplement—2017.

Centers for Disease Control and Prevention, 2017.

US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. A Clinical Practice Guideline.

Centers for Disease Control and Prevention, 2014.

Clinical Resources

American Academy of HIV Medicine | Supporting the HIV Care Provider and the Profession.

Brief Sexual History Tool.

Centers for Disease Control and Prevention.

Database of Antiretroviral Drug Interactions.

HIV Insite. University of California, San Francisco.

Fast-Track Cities.

International Association of Providers of AIDS Care (IAPAC), 2018.

HIV Drug Interactions.

University of Liverpool (Web site), 2018.

HIV in the United States by Geography.

Centers for Disease Control and Prevention, 2018.

PrEP Kit.

AIDS United, 2015.

Provider Information Sheet: PrEP During Conception, Pregnancy, and Breastfeeding.

Centers for Disease Control and Prevention.

State HIV Laws.

Centers for Disease Control and Prevention, 2018.

Taking a Sexual History.

NYC Health, 2015.

Transgender Health Learning Center.

University of California, San Francisco, 2018.

Patient Resources

HIV Risk Reduction Estimator.

Centers for Disease Control and Prevention, 2017

Centers for Disease Control and Prevention (CDC): HIV Basics.

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including preexposure prophylaxis (PrEP).

Pill-Reminder Smartphone Apps (Free).

Mango Health – Medicine Manager, Pill Reminder for iPhone.

Mango Health for Android.

Medisafe Pill Reminder, Rx, & Medicine Tracker for iPhone.

Medisafe Meds & Pill Reminder for Android.

Positively Aware.

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for men who have sex with men and transgender people.

PrEP for U.S. Women: A Collection of Resources.

HIVE (Website).
HIVE provides preconception and prenatal care and resources for women and couples affected by HIV.

Suggested Readings

Removing the stigma of HIV.

American Pharmacists Association, 2017.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410

Evaluating the impact of a pharmacist-led antiretroviral stewardship program on reducing drug interactions in HIV-infected patients.

Billedo JAS, et al. J Int Assoc Provid AIDS Care. 2016;15(1):84-88

Benefit of continuous/immediate ART on disease risk: SMART & START combined analysis.

Borges AH, et al. 24th Conference on Retroviruses and Opportunistic Infections; February 13−16, 2017; Seattle, WA. Abstract 474.

Pharmacists as providers of HIV pre-exposure prophylaxis.

Bruno C, Saberi P. Int J Clin Pharm. 2012;34(6):803-806.

Frequency of HIV testing and time from infection to diagnosis improve.

Centers for Disease Control and Prevention, 2017.

Innovative CDC effort expands HIV testing into pharmacies.

Centers for Disease Control and Prevention, 2012.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Pharmacist-provided rapid HIV testing in two community pharmacies.

Darin KM, et al. J Am Pharm Assoc (2003). 2015;55(1):81-88.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.

90-90-90: An ambitious treatment target to help end the AIDS epidemic.

Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014.

Assessment of the benefits of and barriers to HIV pharmacist credentialing.

McLaughlin M, et al. J Am Pharm Assoc (2003). 2018.

What is PrEP?

PrEP REP project.

Initiation of antiretroviral therapy in early asymptomatic HIV infection.

The INSIGHT START Study Group. N Engl J Med. 2015;373(9):795-807.

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes


Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies